These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 310270)

  • 1. Penetration of atenolol in the rabbit eye.
    Ros FE; Innemee HC; van Zwieten PA
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1978 Nov; 208(4):235-40. PubMed ID: 310270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol.
    Ros FE; Innemee HC; van Zwieten PA
    Doc Ophthalmol; 1980 Apr; 48(2):291-301. PubMed ID: 6105048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tokolysis and dose-dependent effects of beta-blocking with atenolol in the rabbit].
    Steib L; Czekelius P; Behr J
    Z Geburtshilfe Perinatol; 1982; 186(3):145-9. PubMed ID: 6889791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atenolol on blood pressure, heart rate, renin, and norepinephrine during exercise.
    Winer N; Mason WD; Carter CH; Willoughby TL; Kochak GM; Cohen I; Bell RM
    Clin Pharmacol Ther; 1979 Sep; 26(3):315-25. PubMed ID: 466925
    [No Abstract]   [Full Text] [Related]  

  • 5. Formulation influence on ocular and systemic absorption of topically applied atenolol in the pigmented rabbit.
    Lee YH; Lee VH
    J Ocul Pharmacol; 1993; 9(1):47-58. PubMed ID: 8463732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of circulatory responsiveness following the sudden withdrawal from atenolol and propranolol.
    Schwartz J; Jackson G; Kates RE; Harrison DC
    Eur Heart J; 1981 Feb; 2(1):31-9. PubMed ID: 7274264
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison between the acute hemodynamic effects and brain penetration of atenolol and metoprolol.
    van Zwieten PA; Timmermans PB
    J Cardiovasc Pharmacol; 1979; 1(1):85-96. PubMed ID: 94385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Penetration of timolol into the rabbit eye. Measurements after ocular instillation and intravenous injection.
    Schmitt CJ; Lotti VJ; LeDouarec JC
    Arch Ophthalmol; 1980 Mar; 98(3):547-51. PubMed ID: 7362514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response to atenolol in arterial hypertension in relation to renal function, pharmacokinetics and renin activity.
    Zech PY; Labeeuw M; Pozet N; Hadj-Aissa A; Sassard J; McAinsh J
    Postgrad Med J; 1977; 53 Suppl 3():134-41. PubMed ID: 928260
    [No Abstract]   [Full Text] [Related]  

  • 10. L-662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals.
    Sugrue MF; Gautheron P; Mallorga P; Nolan TE; Graham SL; Schwam H; Shepard KL; Smith RL
    Br J Pharmacol; 1990 Jan; 99(1):59-64. PubMed ID: 2110013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic atenolol treatment and hypertension development in spontaneously hypertensive rats.
    Richer C; Boissier JR; Giudicelli JF
    Eur J Pharmacol; 1978 Feb; 47(4):393-400. PubMed ID: 631188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effect of intravenous administration of atenolol and practolol on resting and exercise-evoked increase in heart rate and cardiac work load in normal human subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):27-30. PubMed ID: 838525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular disposition of aminozolamide in the rabbit eye.
    Putnam ML; Schoenwald RD; Duffel MW; Barfknecht CF; Segarra TM; Campbell DA
    Invest Ophthalmol Vis Sci; 1987 Aug; 28(8):1373-82. PubMed ID: 3610554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The duration of action of atenolol in man [proceedings].
    Harry JD; Young J
    Br J Clin Pharmacol; 1977 Jun; 4(3):387P-388P. PubMed ID: 901711
    [No Abstract]   [Full Text] [Related]  

  • 15. Distribution of brimonidine into anterior and posterior tissues of monkey, rabbit, and rat eyes.
    Acheampong AA; Shackleton M; John B; Burke J; Wheeler L; Tang-Liu D
    Drug Metab Dispos; 2002 Apr; 30(4):421-9. PubMed ID: 11901096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration.
    Shanks RG; Carruthers SG; Kelly JG; McDevitt DG
    Postgrad Med J; 1977; 53 Suppl 3():70-3. PubMed ID: 928269
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose response for blood pressure and degree of cardiac beta-blockade with atenolol.
    Marshall AJ; Barritt DW; Heaton S; Harry JD
    Postgrad Med J; 1979 Sep; 55(646):537-40. PubMed ID: 390528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ocular penetration of UF-021, a new prostaglandin related compound, in the rabbit eye].
    Watanabe C; Matsumoto S; Kin K; Tsuchisaka H; Ueno R
    Nippon Ganka Gakkai Zasshi; 1992 Mar; 96(3):335-9. PubMed ID: 1580216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oral atenolol and propranolol on blood pressure, heart rate and plasma cyclic adenosine 3':5'-monophosphate in borderline hypertensive patients.
    González-Gómez A; García-Barreto D; Cabrera R; Toruncha A; Hernández-Cañero A
    Pharmacology; 1982; 25(1):33-8. PubMed ID: 6289362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The demonstration of atenolol as a beta-adrenoceptor blocking drug in man.
    Harry JD
    Postgrad Med J; 1977; 53 Suppl 3():65-9. PubMed ID: 928268
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.